{
    "Trade/Device Name(s)": [
        "WaveSense Jazz Wireless Blood Glucose Monitoring System",
        "Jazz Wireless Blood Glucose Monitoring System",
        "Jazz Wireless Blood Glucose Meter",
        "Jazz Blood Glucose Test Strips",
        "WaveSense Control Solution"
    ],
    "Submitter Information": "AgaMatrix, Inc.",
    "510(k) Number": "K083265",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "January 5, 2009",
    "Summary Letter Received Date": "January 6, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Jazz Wireless Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Meter",
        "Test Strips",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for AgaMatrix Jazz Wireless Blood Glucose Monitoring System for quantitative measurement of blood glucose in fresh capillary whole blood",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh capillary whole blood for home use or clinical settings, as an aid to monitor diabetes control",
    "fda_folder": "Clinical Chemistry"
}